Randomised controlled trial evaluating the role of tirofiban in high-risk non-ST elevation acute coronary syndromes: an East Indian perspective

Glycoprotein IIb/IIIa inhibitors such as tirofiban inhibit platelet aggregation. We evaluated the immediate and early outcomes in patients with high-risk non-ST elevation acute coronary syndrome (NSTE ACS) who received tirofiban with conventional therapy compared to patients who received only conven...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Singapore medical journal 2010-07, Vol.51 (7), p.558-564
Hauptverfasser:	Bhattacharya, R, Pani, A, Dutta, D, Basak, S, Gangopadhyay, S, Das Baksi, S, Sarkar, R N
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - diagnosis Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - mortality Aged Aspirin - administration & dosage Dose-Response Relationship, Drug Drug Administration Schedule Drug Therapy, Combination Electrocardiography Emergency Service, Hospital Enoxaparin - administration & dosage Female Follow-Up Studies Humans India Kaplan-Meier Estimate Male Middle Aged Platelet Aggregation Inhibitors - administration & dosage Reference Values Severity of Illness Index Survival Rate Ticlopidine - administration & dosage Ticlopidine - analogs & derivatives Treatment Outcome Tyrosine - administration & dosage Tyrosine - analogs & derivatives
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!